Bernard E, Dubois J L, Wepierre J
Laboratoire de dermophamacologie, Faculté de Pharmacie, Châtenay-Malabry, France.
J Pharm Sci. 1997 May;86(5):573-8. doi: 10.1021/js960394l.
The significance of the sebaceous gland pathway in the cutaneous permeation of an antiandrogen, 4-[3-(4-hydroxybutyl)-4,4-dimethyl -2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrile (RU 58841), was studied with normal hairless rat skin and an induced scar hairless rat skin without sebaceous glands. RU 58841 was dissolved in an alcoholic solution and encapsulated in liposomes for comparison. After 24 h, the cumulative percentage of RU 58841 absorbed in vitro was 3-4-fold higher in the normal skin than in the scar skin; in the case of liposomes, the accumulation of the drug in the normal dermis was significantly higher than in the scar one. In the in vivo cutaneous distribution, the epidermis and dermis of the normal skin contained higher amounts of RU 58841 than the scar skin (ninefold with the solution and 16-fold with liposomes). An autoradiography study showed that with the solution, the drug was mainly localized in the stratum corneum/epidermis, and with the liposomes, the drug was mainly localized in the sebaceous glands. We concluded that the sebaceous glands constituted the main pathway for RU 58841. The alcoholic solution encouraged the localization of the drug into the stratum corneum, whereas liposomes targeted the sebaceous glands.
利用正常无毛大鼠皮肤和诱导形成的无皮脂腺瘢痕无毛大鼠皮肤,研究了皮脂腺途径在抗雄激素药物4-[3-(4-羟丁基)-4,4-二甲基-2,5-二氧代-1-咪唑烷基]-2-(三氟甲基)苯甲腈(RU 58841)经皮渗透中的意义。将RU 58841溶解于乙醇溶液中并包封于脂质体中进行比较。24小时后,RU 58841在体外的累积吸收百分比在正常皮肤中比瘢痕皮肤高3至4倍;对于脂质体,药物在正常真皮中的蓄积明显高于瘢痕皮肤。在体内皮肤分布方面,正常皮肤的表皮和真皮中RU 58841的含量高于瘢痕皮肤(溶液给药时高9倍,脂质体给药时高16倍)。放射自显影研究表明,溶液给药时,药物主要定位于角质层/表皮,脂质体给药时,药物主要定位于皮脂腺。我们得出结论,皮脂腺构成了RU 58841的主要途径。乙醇溶液促使药物定位于角质层,而脂质体靶向皮脂腺。